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ABSTRACT
Purpose: We set out to estimate the prevalence of trachoma and access to water and sanitation in
seven suspected-trachoma-endemic districts of northern Congo, surveyed as a single evaluation unit.
Methods: From a complete list of rural villages in the seven districts, we systematically selected 22
with probability proportional to village size. In selected villages, we included all households where
there were fewer than 25 in total, or used compact segment sampling to select a group of
approximately 20 households by random draw. In each selected household, all consenting
residents aged ≥1 year were examined by Global Trachoma Mapping Project-certified trachoma
graders, and data collected on household-level access to water and sanitation.
Results: In November and December 2015, 466 households were visited in 22 villages, and 2081
(88%) of 2377 residents of those households were examined. No examined individual had
trichiasis. The age-adjusted prevalence of the active trachoma sign trachomatous inflammation
—follicular (TF) in 1–9-year-olds was 2.5% (95%CI 0.9–4.5%). Only 39% (95%CI 35–44%) of house-
holds had access to an improved source of drinking water. Only 10% (95%CI 7–13%) of house-
holds had access to an improved sanitation facility.
Conclusion: Trachoma is not a public health problem in this part of Congo. Access to water and
sanitation is inadequate.
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Introduction
The fight against blinding diseases is a public health
priority for the Republic of the Congo. Political will to
prevent visual impairment prompted the establishment
of both a National Program to Fight Blindness and
a National Program for Onchocerciasis Control.
Congo does not feature in the existing scientific
literature on trachoma.1 However, the country borders
districts of south-western Central African Republic that
are reported to be heavily trachoma-endemic.2 Health
workers on a 2014 Médecins du Monde mission iden-
tified conjunctivitis consistent with active trachoma
[unpublished data] in two departments of Congo adja-
cent to that Central African Republic focus: Sangha and
Likouala departments (Figure 1). Rather than plan
widespread trachoma mapping in Congo, it was
decided to undertake surveys in areas thought to be at
particular risk, with the results to be used to determine
whether further investigation in Congo would be
needed. (An analogous approach was also undertaken
in Democratic Republic of the Congo and
Zimbabwe.3,4) The districts identified for mapping
were Mokéko and Ouesso of Sangha Department, and
Impfondo, Epéna, Dongou, Betou and Enyelle of
Likouala Department (Figure 1). These seven districts
were grouped as a single evaluation unit (EU) with an
estimated combined population of 189,656.
Trachoma mapping involves the conduct of popula-
tion-based prevalence surveys, generally in EUs of
100,000–250,000 people.5–7 This allows programmes to
identify populations in need of the surgical, medical,
educational and environmental interventions of tracho-
ma’s elimination strategy, which is summarized by the
acronym SAFE8,9: surgery for trachomatous trichiasis,10
antibiotics to clear ocular Chlamydia trachomatis
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infection,11 and facial cleanliness12 and environmental
improvement13 to reduce transmission of C. trachomatis.
The objectives of this cross-sectional survey were
to estimate the prevalence of trachomatous inflam-
mation—follicular (TF)14 in 1–9-year-olds (a proxy
for the prevalence of ocular C. trachomatis
infection15,16), to estimate the prevalence of tracho-
matous trichiasis14 in ≥15-year-olds, and to estimate
the prevalence of household-level access to water and
sanitation.
Figure 1. Map of the Republic of the Congo showing area mapped for trachoma, 2015.
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Material and methods
Study population and sample size
A single survey was undertaken, covering all seven
districts. The base population was all non-urban resi-
dents of those districts, as projected to 2015 from the
2007 population census.17 After excluding the urban
areas of Betou (estimated population 8188), Ouesso
Town (31,882), Impfondo (29,823), and Pokola
(18,040), an estimated 101,723 people remained as resi-
dents of the EU. We followed the principles and pro-
cesses of the Global Trachoma Mapping Project
(GTMP),18 and determined sample size based on con-
siderations relating to TF, as previously described.19 To
estimate with 95% confidence a hypothesized 10% TF
prevalence in 1–9-year-olds, using a design effect of
2.65 and desired precision of ±3%, we aimed to exam-
ine 1019 children.19 Since census data indicated that
Congo households had a mean of 6.9 residents, 27% of
whom would be aged 1–9 years,17 and because we
inflated the number of households to be visited by
20% to allow for non-response, we planned to include
at least 656 households in the survey.
Team composition and training
Two field teams were trained. Each consisted of
a Senior Ophthalmic Technician trained and certified
as a grader by the GTMP19; a data recorder; a driver-
mechanic or experienced boat driver with knowledge of
the locality; and a local guide, where necessary, to
facilitate communication in local dialects. To ensure
the presence of signs of trachoma for grader training
and testing purposes,19 training of graders and recor-
ders was undertaken in Sudan, where many children
have active trachoma,20 in November 2015, with the
full agreement of Sudanese authorities. Version 3 of the
GTMP training system21 was used.
Sampling
From a complete list of villages in the seven districts, 22
villages (clusters) were systematically selected with prob-
ability proportional to the size of the village population.5 In
each village, we planned to have theChief use randomdraw
to select a compact segment of 30 households, anticipating,
based on experience in other countries,4,22–25 that a field
team would be able to visit 30 households in one day. All
households in the selected segment would then be visited
and the residents of those households invited to participate,
with 22 clusters of 30 households providing a total of 660
households for the survey. Conditions on the ground,
however, made visiting 30 households per day difficult:
many villages had fewer than 30 households, and it was
often necessary tomove fromhouse to house by boat. After
pilot fieldwork, the number of households to be visited per
village was revised to 20. When selected villages had fewer
than 25 households, field teams conducted an exhaustive
survey of those households. In seven larger villages, a sketch
map was drawn with the help of the village chief or another
key informant, and blocks of 20 households were demar-
cated.One blockwas then selected by randomdraw.Where
division of the village into segments of 20 households was
politically or numerically problematic, a slightly larger
(rather than slightly smaller) number was preferred. All
persons aged 12 months and over who, at the time of the
survey, were currently resident and had resided for at least
the previous sixmonths in a selected household, were asked
to consent to be examined. Households and individuals
who declined to participate were not replaced.
Fieldwork
Teams worked under the supervision of the National
Coordinator of the Onchocerciasis Control Program
(FM). At each household, the team recorded global
positioning system coordinates, obtained informed
verbal consent, and recorded residents’ responses to
questions about access to water and sanitation, in
inspecting (where present) the households latrine,
in accordance with the GTMP standard protocol.19
Both eyes of each consenting individual were exam-
ined by a GTMP-certified grader, who used
a binocular loupe (magnification 2.5) and good
light to examine for trichiasis, TF, and trachomatous
inflammation—intense.14 The definition of the WHO
simplified trachoma grading scheme14 were applied
for each sign. Data were recorded in the GTMP
Android smartphone app. Individuals with active
trachoma were given topical 1% tetracycline oint-
ment to be used twice daily for six weeks.
Individuals with trichiasis were informed of the
risks of the disease and referred to the nearest med-
ical center for surgery. In order to prevent pathogens
from being transferred from one examinee to the
next, graders cleaned their hands with alcohol gel
after each examination.
When a resident 1–9-year-old was absent at the time of
the field team’s first visit, the team returned to the same
home a second time in the same day. If the individual was
not then found, he or she was declared “absent.”
Data were uploaded to the GTMP server at the end of
each day, and cleaned, analyzed and approved as described
in detail elsewhere.19 In brief, cluster-level data on TF were
adjusted for the age of those examined, and cluster-level
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data on trichiasis were adjusted by the age and gender of
those examined. We used the arithmetic means of the
adjusted cluster-level proportions as the evaluation-unit-
level prevalence estimates of each of these signs.
Confidence intervals (CIs) were determined by bootstrap-
ping, with 10,000 replications. For the prevalence of access
to water and sanitation at household level, CIs were calcu-
lated assuming a normal distribution.26
Ethical considerations
Protocols were approved by the National Ethics/
Bioethics Committee (000705/MSP/CAB/DGELM-15)
and the London School of Hygiene & Tropical
Medicine (6319 and 8355). Verbal consent was
obtained from all participants (or their parents or guar-
dians, in the case of children). Data were only collected
on eligible, consenting subjects. As indicated above,
antibiotics or referral for surgery were provided, as
indicated. Both antibiotics and trichiasis surgery were
available at no cost to participants who needed them.
Results
Fieldwork was undertaken from November 28, 2015 to
December 20, 2015. A total of 466 households were
visited in 22 villages across the seven districts, and
2377 residents aged ≥1 year were enumerated; 2081
(88%) of them were examined. The number of house-
holds included per village ranged from 20 to 25
(mean 21.2).
In the ≥15-year-old age group, 963 individuals were
enumerated, of whom 269 were absent, 0 refused to be
examined and 694 were examined. No cases of trichia-
sis were identified.
In the 1–9-year-old age group, 1237 individuals were
enumerated, of whom 15 were absent, 0 refused to be
examined, and 1222 were examined. Three cases of TI
and 33 cases of TF were identified in 1–9-year-olds. The
age-adjusted prevalence of TF in 1–9-year-olds was 2.5%
(95%CI 0.9–4.5%).
Only 39% (95%CI 35–44%) of households had access
to an improved source of drinking water (a household
mains connection, public standpipe, borehole, protected
dug well, protected spring or rainwater collection) in the
dry season. Only 10% (95%CI 7–13%) of households had
access to their own improved sanitation facility (specifi-
cally, connection to a public sewer, connection to a septic
system, a pour-flush latrine, a covered pit latrine, or
a ventilated improved pit latrine).
Discussion
In this study, we employed the momentum,18,27
systems19,28 and funding29 of the GTMP to investigate
whether trachoma was a public health problem in an
area felt to be the most at-risk part of the Republic of
the Congo, a hitherto-unsurveyed country. This survey
was set up as the epidemiological equivalent of a canary
in the mine, with the understanding that finding tra-
choma at levels indicative of a public health problem
here would prompt further trachoma surveys in sur-
rounding health districts,3,4 and potentially further
afield. We did not find trachoma at levels indicative
of a public health problem, and (following the example
of similar trachoma mapping exercises in Kogi and
Kwara states of Nigeria30,31) do not now believe that
such further mapping is justified (though refugee popu-
lations here may still need to be separately considered).
This is good news for the global trachoma community,
which is currently working to achieve global elimina-
tion targets set more than two decades ago.32
As in many of the environments in which the GTMP
operated,3,20,33–36 local conditions in Congo made field-
work a complicated business. The villages sampled here
were mostly distributed along more-or-less-navigable
rivers, on land that was often flooded. Boats were
usually the best—and sometimes the only—means of
access. Completion of the survey was a credit to the
field teams, who negotiated the terrain without com-
plaint and returned data of high quality.28,37
There was, however, one particular shortcoming in our
survey. Because of access issues and the spatial distribution
of households, as noted in theMethods section above, itwas
not possible to include 30 households in each village.
Trachoma clusters geographically at various scales,38,39 so
the smaller number of households enrolled per cluster
might have reduced the robustness of our prevalence esti-
mates; the extent to which this is problematic is difficult to
estimate. Fortunately, the average number of children resi-
dent in each household was considerably higher than we
had planned for, based on national averages derived from
census data. Thismeant that we achieved our sample size of
1–9-year-olds with a lower total number of households
recruited than initially planned. However, we were able to
enumerate only 963 ≥15-year-olds, and able to examine
only 694 of them, the rest being absent from the household
on the day it was visited. (The adults of these—mostly
indigenous—communities, who are somewhat margina-
lized, were often unwilling to be examined or even enum-
erated.) A relatively wide confidence interval for a non-zero
estimate of trichiasis prevalence could have been the result,
had we observed any trichiasis cases. The lack of trichiasis
in the individuals examined, and the informal
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corroborating accounts of local health workers (for whom
trichiasis is not known as a presentation) give us some
confidence in reporting a trichiasis prevalence of 0%.
A systematic survey of eyecare workers nationally, asking
about presentations of trichiasis, might help to further
reinforce the view that trichiasis is rare or absent. In the
meantime, in combination with the TF prevalence in 1–-
9-year-olds of 2.5%, we feel it is reasonable to propose that
trachoma is unlikely to be a public health problem in this
population.
Data on access to water and sanitation are useful to
trachoma andother neglected tropical disease programmes,
for advocacy and monitoring purposes.40 The fact that
a trachoma elimination programme will not be needed
here does not devalue the water and sanitation information
we collected, which suggests that most people in these
health districts live in households inwhich thewater source,
means of solid human waste disposal, or both, are unim-
proved. Low levels of access to sanitation are linked to
a number of infectious diseases and adverse health
outcomes.41,42 There is an urgent need in this part of
Congo for provision of better infrastructure for water and
sanitation.
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